Your browser doesn't support javascript.
loading
Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors.
Francis, Jasmine H; Barker, Christopher A; Canestraro, Julia; Abramson, David H; Shoushtari, Alexander N.
Afiliação
  • Francis JH; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Barker CA; Weill Cornell Medical College, New York, NY, USA.
  • Canestraro J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Abramson DH; Weill Cornell Medical College, New York, NY, USA.
  • Shoushtari AN; Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Am J Ophthalmol Case Rep ; 34: 102021, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38444640
ABSTRACT

Purpose:

To report a case of metastatic uveal melanoma treated with immune checkpoint inhibition in which serial circulating tumor DNA (ctDNA) was assessed throughout treatment. Observations A 33-year-old man was diagnosed with metastatic uveal melanoma and initially had progression of disease following hepatic embolization and nivolumab/ipilimumab. At the time, plasma ctDNA GNA11 and SF3B1 were measurable and repeat ctDNA showed increased variant allele frequency following further progression of disease on vorinostat. Following additional nivolumab/ipilimumab, radiographic response was noted and repeat ctDNA became undetectable and remained so at 27 months follow up. Conclusions and importance Clearance of cell free DNA in metastatic uveal melanoma may be associated with radiographic response to immune checkpoint inhibitors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Ophthalmol Case Rep Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Ophthalmol Case Rep Ano de publicação: 2024 Tipo de documento: Article